S&P 500 Financials Sector SEC Filings — March 16, 2026

16-03-2026

Kennedy-Wilson Holdings, Inc. amended its Merger Agreement on March 15, 2026, with Kona Bidco, LLC and Kona Merger Sub, originally dated February 16, 2026, to require a two-thirds affirmative vote of the Company's common stock, Series A, B, and C preferred stock (on specified bases), excluding shares owned by William J. McMorrow, Matthew Windisch, In Ku Lee, and certain Fairfax Financial affiliates to comply with DGCL Section 203. This DEFA14A filing serves as soliciting material for the shareholder vote on the merger. The amendment highlights potential risks including failure to obtain approval, termination fees, operational disruptions, and stock price decline if the deal fails.

• ·Merger requires approval excluding Company Voting Stock 'owned' by specified persons and their affiliates/associates per DGCL Section 203.
• ·2025 annual meeting proxy filed April 25, 2025, contains director/executive info.

16-03-2026

Bluejay Diagnostics, Inc. issued a response letter on March 13, 2026, to NorthStrive Fund II LP acknowledging their March 11 suggestion to pursue acquisition of a Phase-1-ready therapeutic program for refractory chronic cough. The company emphasized its primary focus on advancing the Symphony™ platform, completing the SYMON™ II clinical study, manufacturing scale-up, and FDA submission preparations to preserve cash and unlock shareholder value. While open to evaluating the opportunity with advisors, Bluejay noted the limited information provided and requested additional diligence.

• ·Company address: 360 Massachusetts Avenue, Suite 203, Acton, MA 01720
• ·NorthStrive address: 120 Newport Center Drive, Newport Beach, CA 92660

16-03-2026

Alto Neuroscience reported a net loss of $63.2M for the year ended December 31, 2025, widening 3% YoY from $61.4M, primarily due to lower interest income, interest expense, and a $0.7M loss on debt extinguishment, despite a 3% reduction in total operating expenses to $66.4M from $68.6M. Cash and equivalents increased 5% to $176.5M, bolstered by $60.1M in financing activities including a private placement, though net cash used in operations rose 9% to $51.8M. Stockholders' equity remained nearly flat at $151.1M, down slightly from $151.5M.

• ·Term loan increased to $16.7M non-current from $10.3M.
• ·Stock-based compensation expense rose to $8.1M from $7.6M.
• ·Private placement proceeds $50.0M net of costs.
• ·IPO in 2024 raised $133.0M net.
• ·Total liabilities increased to $33.5M from $26.1M.

16-03-2026

Ferguson Enterprises Inc. issued definitive additional proxy materials for its 2026 Annual Meeting on April 30, 2026, at 4:00 p.m. ET virtually, seeking shareholder votes to elect 11 director nominees, ratify Deloitte & Touche LLP as independent auditors for fiscal 2026, and approve on an advisory basis the compensation of Named Executive Officers for the five-month transition period from August 1, 2025, to December 31, 2025. Proxy materials are available online at www.proxyvote.com, with requests for paper/email copies due by April 16, 2026 (April 9 for U.K. stockholders). Voting must be completed by April 29, 2026, 11:59 p.m. ET.

• ·Virtual meeting access: www.virtualshareholdermeeting.com/FERG2026
• ·U.K. stockholder contact: Corporate Secretariat, c/o Ferguson Group Services Limited, 1020 Eskdale Road, Winnersh Triangle, Wokingham, RG41 5TS; +44-118-927-3810; corporate.secretary@ferguson.com

16-03-2026

CoStar Group, Inc. (NASDAQ: CSGP) appointed Nana Banerjee as a new independent director to its Board of Directors, effective immediately on March 16, 2026, expanding the board to nine members with eight independent directors. Banerjee brings over two decades of experience in leading technology, data, AI, and analytics businesses from roles including CEO of Pelmorex Corp., Senior Managing Director at Cerberus Capital Management, and CEO of McGraw-Hill. The appointment supports the company's long-term growth strategy in AI and advanced analytics, as stated by CEO Andy Florance and Board Chair Louise Sams.

• ·CoStar Group’s websites attracted over 139 million average monthly unique visitors in the fourth quarter of 2025.
• ·Founded in 1986 and headquartered in Arlington, Virginia.

16-03-2026

Townsquare Media reported net revenue of $427.4M for 2025, down 5.2% YoY from $451.0M, primarily due to a 12.6% decline in Broadcast Advertising revenue while Digital Advertising grew 1.6% and Subscription Digital Marketing Solutions was flat at -0.7%. Operating income more than doubled to $44.2M (up 103.8% YoY) from cost reductions including lower impairments (-76.4%) and stock-based compensation (-19.8%), narrowing net loss to $9.8M (-10.8% YoY). However, cash from operations fell 37.2% to $30.6M, cash equivalents dropped to $4.8M, and interest expense rose 32.3% to $47.9M.

• ·Total stockholders’ deficit widened to $41.0M from $28.4M.
• ·Impairment charges decreased 76.4% to $8.9M.
• ·Transaction and business realignment costs increased 137.5% to $11.7M.
• ·Basic and diluted loss per share improved to $(0.71) from $(0.81).

16-03-2026

James Dunne III notified the Board of Directors of American International Group, Inc. (AIG) on March 10, 2026, that he will not stand for re-election at the 2026 Annual Meeting of Shareholders scheduled for May 13, 2026. Mr. Dunne cited no disagreement with the Company's operations, policies, or practices and will continue serving on the Board and the Compensation and Management Resources Committee until the meeting. The 8-K filing was submitted on March 16, 2026.

• ·Date of earliest event reported: March 10, 2026
• ·AIG's principal executive offices: 1271 Avenue of the Americas, New York, New York 10020
• ·AIG common stock trades on NYSE under symbol AIG, par value $2.50 per share

16-03-2026

iQIYI, Inc. reported FY2025 total revenues of RMB 27.3B ($3.9B), down 6.6% YoY from RMB 29.2B in FY2024, with all segments declining: membership services -5.4% to RMB 16.8B ($2.4B), online advertising -9.1% to RMB 5.2B ($743M), and others flat to slightly down. While cost of revenues improved 1.9% to RMB 21.5B ($3.1B) and cash equivalents rose to RMB 4.4B ($623M), operating income plummeted 87% to RMB 229M ($33M) and the company swung to a net loss of RMB 204M ($29M) from a profit of RMB 791M prior year.

• ·FY2025 diluted EPS (ADS) of -$0.03 vs $0.79 in FY2024.
• ·Total assets end FY2025 RMB 46.7B ($6.7B), up slightly from RMB 45.8B end FY2024.
• ·Share count basic increased to 6.75B in FY2025 from 6.73B in FY2024 (flat growth).

16-03-2026

Mawson Infrastructure Group Inc. provided an update on strategic initiatives achieved in fiscal 2025, including regaining Nasdaq compliance, settling lawsuits that reduced current liabilities by $19M, and initiating a pivot to artificial intelligence and high-performance computing. The Board formed a Strategic Transactions Committee, assisted by advisors, to evaluate M&A, joint ventures, and other opportunities to maximize stockholder value, though no specific outcomes or timeline are assured. Interim CEO Kaliste Saloom will present at the Emerging Growth Conference on April 2, 2026.

• ·Expects to file Form 10-K for year ended December 31, 2025, on March 31, 2026.
• ·Preliminary unaudited results for 2025 fourth quarter and fiscal year available at https://www.mawsoninc.com/ under “Press Releases.”
• ·Emerging Growth Conference presentation: April 2, 2026, approximately 2:55 p.m. to 3:05 p.m. Eastern Time; register at https://goto.webcasts.com/starthere.jsp?ei=1748971&tp_key=add80b0ab6&sti=migi; archived webcast on EmergingGrowth.com and YouTube.

16-03-2026

Universal Corporation filed an 8-K/A amendment to disclose compensation details for Steven S. Diel, elected as Senior Vice President and Chief Financial Officer effective April 1, 2026. His package includes an annual base salary of $490,000, target bonus of $350,000, long-term incentive equity awards targeted at $560,000, and a one-time grant of restricted stock units (RSUs) valued at approximately $1.2 million under the 2023 Stock Incentive Plan. The RSUs vest one-third annually on April 1, 2027, 2028, and 2029, subject to continued employment.

• ·Compensation approved by Compensation Committee on March 10, 2026
• ·Initial 8-K filed on February 9, 2026 regarding election on February 3, 2026
• ·RSUs earn dividend equivalent units during vesting periods

16-03-2026

AH Realty Trust (NYSE: AHRT), formerly Armada Hoffler, entered a binding agreement to sell 11 multifamily properties to an affiliate of Harbor Group International for $562M in cash, with a $15M nonrefundable deposit, expected to close mid-2026 subject to customary conditions. Proceeds will fund debt reduction toward a 5.5x-6.5x net debt to adjusted EBITDA target, simplifying the platform and focusing on retail/office. The company is also in advanced negotiations to sell two real estate financing investments for ~$63M, though no assurances of closing.

• ·Retains Smith’s Landing multifamily asset; intends to market Everly and Solis Gainesville for sale.
• ·Transaction formalizes February 16, 2026 letter of intent.
• ·Rebranded as AH Realty Trust effective March 2, 2026 (NYSE: AHRT).
• ·Restructuring also includes divesting construction and real estate financing businesses; targeting retail acquisitions.

16-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 16, 2026, announcing via attached press release (Exhibit 99.1) the cancellation of a previously proposed increase in authorized shares following a reverse stock split. The disclosure is furnished under Item 8.01 and not deemed 'filed' for liability purposes. The report was signed by CEO Steven Reinharz.

16-03-2026

Amphastar Pharmaceuticals, Inc.'s Board of Directors authorized a $50 million increase to the company's share buyback program on March 12, 2026, to primarily offset dilution from equity compensation programs. The program is expected to continue indefinitely, with repurchases potentially made through open market transactions, Rule 10b5-1 plans, privately negotiated deals, or other means in compliance with SEC rules. Timing and volume will depend on factors like share price, regulatory requirements, and market conditions.

• ·Registrant incorporated in Delaware, IRS Employer ID 33-0702205, Nasdaq-listed under AMPH.

16-03-2026

WaterBridge reported Q4 2025 produced water handling volumes of 2.6 million barrels per day, up 1% QoQ, and revenue of $208.9 million, up 2% QoQ, while full-year 2025 volumes grew 15% YoY to 2.4 million barrels per day and pro forma revenue increased 19% YoY to $790.0 million with Adjusted EBITDA of $402.8 million (51% margin). However, Q4 net loss widened to $13.6 million (7% margin), gross margin declined to $46.8 million from $58.3 million QoQ, and borrowings increased to $1.465 billion from $609.4 million YoY. The company initiated a $0.05 per share quarterly dividend and guided 2026 Adjusted EBITDA to $420-460 million with 7-9% growth.

• ·Q4 capital expenditures of $89.2M driven by Speedway Pipeline Phase 1 and Stateline expansions.
• ·2026 capex guidance of $430-490M, primarily for Speedway Phases 1/2 and Devon agreement.
• ·2026 volume guidance of 2,500-2,700 thousand barrels per day.
• ·Single-day volume record of 2.9 million barrels per day in Q4 2025.
• ·99.7% operational uptime and <1% measurement variance for FY 2025.
• ·Phase II Speedway expected to add 500,000 bpd capacity in Eddy/Lea counties, NM.
• ·Dividend record date March 5, 2026; payable March 19, 2026.
• ·IPO closed September 18, 2025; Combination assumed January 1, 2024 for pro forma.

16-03-2026

Urgently reported Q4 2025 revenue of $33.3M, up 4% YoY, gross profit of $8.7M (+23% YoY) with margin expansion to 26% (vs 22%), GAAP operating loss of $2.5M (improved 46% YoY), and non-GAAP operating income of $0.2M. However, full-year 2025 revenue declined 10% YoY to $129.2M despite gross profit growth of 4% and significant operating expense reductions (GAAP -29%, non-GAAP -32%). The company announced a definitive merger agreement to be acquired by Agero, Inc., leading to cancellation of the earnings call and suspension of 2026 guidance.

• ·Q4 consumer satisfaction score of 4.7/5; FY score of 4.6/5.
• ·Cash and equivalents declined to $5.3M as of Dec 31, 2025 from $14.2M prior year.
• ·Total liabilities increased to $90.1M from $85.7M; stockholders' deficit widened to $46.4M from $31.7M.
• ·Q4 net loss of $4.2M improved from $8.7M YoY; FY net loss $20.4M improved from $44.0M.
• ·Revolving credit facility $12.7M as current liability Dec 31, 2025.

16-03-2026

Consolidated revenue decreased 34% YoY to $6.2M for the year ended December 31, 2025, from $9.4M in 2024, due to strategic discontinuation of unprofitable pathology services and cost reductions. However, CyPath® Lung testing revenue grew 87% YoY to $963K from $516K, driven by a 99% increase to more than 1,200 test results delivered. The company raised $16.9M in gross proceeds from equity transactions to fund operations.

16-03-2026

KORU Medical Systems, Inc. announced the retirement of CEO Linda Tharby effective June 30, 2026, with Adam Kalbermatten appointed as President effective March 15, 2026, and succeeding as CEO on July 1, 2026. Tharby will serve as a non-executive advisor and Board member through December 31, 2026, receiving continued base salary at 50% rate during the advisory period and specific equity vesting, while some PSUs were previously cancelled. Kalbermatten's compensation includes base salary increasing to $525,000 and significant LTI awards totaling up to $1.25M annually.

• ·Tharby ineligible for bonus/incentives post-June 30, 2026; remaining unvested awards forfeited after Dec 31, 2026 except specified tranches.
• ·Kalbermatten eligible for severance including 12 months salary continuation and 100% bonus target upon qualifying termination.
• ·Tharby non-compete and restrictive covenants remain in effect; no equity sales during advisory period without Board approval.

16-03-2026

Option Therapeutics Inc., a pharmaceutical preparations company and wholly owned subsidiary of BioVie (CIK 0002070577), filed an S-1/A registration statement on March 16, 2026 (effective March 13, 2026), ahead of an IPO and planned separation from BioVie, with historical financials presented as carve-outs lacking standalone operating history. Post-offering, BioVie will retain approximately 64% ownership (or 60% if underwriters exercise the over-allotment option), making Option Therapeutics a 'controlled company' under NYSE rules and exempt from certain governance standards like majority independent board requirements. Risks include higher standalone costs, potential management distraction from separation efforts, limited market liquidity without a BioVie distribution of shares, and ongoing conflicts of interest with BioVie.

• ·Fiscal year end: June 30
• ·State of incorporation: Delaware
• ·Business address: 680 W Nye Ln Ste 201, Carson City, NV 89703
• ·SEC file number: 333-292936

16-03-2026

FACT II Acquisition Corp. and Precision Aerospace & Defense Group, Inc. (PAD) hosted an Investor Day on March 12, 2026, to discuss their proposed business combination, highlighting PAD's projected pro forma $130.8M revenue and $25.2M EBITDA across engineering/sustainment, precision manufacturing, and advanced non-destructive testing segments. Leaders emphasized strong market tailwinds in aerospace & defense (31% of end markets), commercial aviation (50%), space, and energy, with a proven M&A strategy for growth; no historical declines or flat performance were disclosed, focusing solely on forward-looking opportunities amid rising U.S. defense budgets projected at $1T for 2026 and $1.5T for 2027.

• ·PAD scales manufacturing and engineering services directly to DoD, major OEMs, and Tier 1 suppliers.
• ·Three existing business lines: Engineering and Sustainment, Precision Manufacturing, Advanced Non-Destructive Testing; fourth line under creation.
• ·Portfolio includes case studies from owned companies with leadership presentations.
• ·Historical experience growing telecom/counter communications company from $100M to $1B sales with 10,000 employees across 40 locations.
• ·300,000 square foot secure facility (skiff) experience in prior roles.

16-03-2026

PCB Bancorp reported net income of $37.5M for the year ended December 31, 2025, up 45% YoY from $25.8M in 2024, with net interest income increasing 17% to $104M and total assets growing 7% to $3.28B alongside loans held-for-investment up 7% to $2.82B. Return on average assets improved to 1.15% and efficiency ratio declined to 51.2% from 60.2%. However, nonaccrual loans rose 69% to $7.9M, NPAs increased to 0.24% of assets from 0.15%, provision for credit losses grew 18% to $4.0M, and capital ratios were slightly lower though still well above regulatory thresholds.

• ·Earnings per common share diluted $2.58 for 2025, up from $1.74 in 2024.
• ·Cash dividends declared per common share $0.80 for 2025, up from $0.72.
• ·Dividend payout ratio 30.89% for 2025, improved from 41.14%.
• ·All capital ratios remain well capitalized per PCA thresholds.
• ·ASC 326 adoption increased total ACL on loans by $1.1M to $26.0M.

16-03-2026

UniFirst spokesperson affirmed the company's nearly 30-year presence and strong commitment to its Owensboro, Kentucky operations, noting the recent completion of a planned facility expansion expected to be operational in early April 2026. This statement was made amid a pending merger transaction with Cintas, accompanied by extensive forward-looking risk disclosures including potential termination rights, regulatory hurdles, integration challenges, and economic uncertainties. No financial metrics or performance data were disclosed.

• ·Statement issued March 13, 2026, to Owensboro Times.
• ·UniFirst 10-K for fiscal year ended August 30, 2025, filed October 29, 2025, disclosed material weakness in internal control over financial reporting.
• ·Cintas 10-K for fiscal year ended May 31, 2025, filed July 28, 2025.

16-03-2026

Silvercrest Asset Management Group Inc. (SAMG) issued a press release on March 13, 2026, announcing a teleconference on March 17, 2026, at 8:30 am Eastern Time to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The press release is furnished as Exhibit 99.1 and not deemed filed under securities laws.

• ·Filing submitted on March 16, 2026, covering Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

16-03-2026

Figure Technology Solutions, Inc. (FIGR) reported robust FY2025 financials with net revenue surging 48.7% YoY to $507M from $341M and net income skyrocketing 574.3% to $134M from $20M, fueled by ecosystem volume growth to $9.1B from $5.9B and strong gains in ecosystem/technology fees (+327%) and partner-branded revenue (+86.8%). However, digital asset marketplace volume declined to $710M from $751M, gain on servicing assets fell 24.7% to $25M, and partner-branded origination fees dropped 10.2%, while several expense categories like operations (+46.4%) and sales/marketing (+36.7%) rose notably. Adjusted EBITDA improved sharply to $251M from $101M, reflecting operational leverage despite mixed segment performance.

• ·Operating income increased 1172.6% to $118M from $9M.
• ·Interest expense declined 13.4% to $49M.
• ·Sales and marketing expenses rose 36.7% to $76M, driven by 80.2% higher compensation.
• ·Technology and product development expenses up modestly 3.6% to $65M.

16-03-2026

Xanadu Quantum Technologies Inc. is discussed in a March 13, 2026 interview by CEO Christian Weedbrook on Unusual Whales, highlighting its photonic quantum computing approach, Borealis quantum computer achievements, and PennyLane software as key differentiators ahead of its business combination with Crane Harbor Acquisition Corp. The company secured up to $300M USD in government funding from Canada for a quantum data center, emphasizing advantages like room-temperature operation, fast gate speeds, and networking capabilities without mentioning any challenges or setbacks. No financial period-over-period data or declines are reported.

• ·Borealis quantum computer solved a math problem in 2 minutes, vs. 7 million years on the world's fastest supercomputer using over 7 million GPUs.
• ·Xanadu networked four independent quantum server racks, scalable to hundreds, per peer-reviewed Nature paper.
• ·Operates at room temperature post-initialization, uses large-scale foundries, and has faster gate speeds than other approaches.

16-03-2026

LivePerson Inc (LPSN) reported FY 2025 revenue of $243.7M, down 22% YoY from $312.5M amid broad declines. Operating expenses decreased significantly across categories, including cost of revenue -10%, sales and marketing -22%, general and administrative -44%, product development -31%, depreciation and amortization -46%, and goodwill impairment -31%, driven by headcount reductions (e.g., product development headcount down 41% to 239). Restructuring costs edged up 5% YoY to $11.7M.

16-03-2026

South Bow Corporation (SOBO), a foreign private issuer, filed its Form 40-F Annual Report for the fiscal year ended December 31, 2025, incorporating the Annual Information Form, audited consolidated financial statements, and MD&A as exhibits. The company reported 208,250,512 common shares outstanding as of December 31, 2025, with shares listed on NYSE and TSX. The filing discloses a material weakness in internal controls over financial reporting (ICFR) with ongoing remediation efforts, and no other changes in ICFR.

• ·Independent auditor: KPMG LLP (Auditor Firm ID: 85).
• ·Principal executive offices: Suite 900, 707 5th Street SW, Calgary, Alberta, Canada T2P 1V8.
• ·U.S. agent for service: South Bow USA Services Inc., 920 Memorial City Way, Suite 800, Houston, Texas 77024.

16-03-2026

Trailblazer Merger Corp I is holding a special stockholder meeting on March 27, 2026, to vote on amending its charter and trust agreement to extend the business combination deadline from March 30, 2026, up to three one-month increments until June 30, 2026, to facilitate its pending merger with Cyabra Strategy Ltd., with sponsor deposits of $0.035 per unredeemed public share per extension. The trust account balance is $4.03M as of March 11, 2026, yielding a $12.11 per share redemption price, while public shares trade at a discount of $10.75. Without approval, the company faces dissolution and liquidation after the current termination date.

• ·Merger agreement originally dated July 22, 2024, and amended November 11, 2024, and November 6, 2025.
• ·Special Meeting via teleconference: US toll-free 877-853-5257 or 888-475-4499; Meeting ID 917-9737-9034; Passcode 619829.

16-03-2026

TSS, Inc. (TSSI) filed an 8-K/A amendment on March 13, 2026 (filed March 16, 2026) to correct the Fourth Quarter Net Income in its March 11, 2026 press release, reducing the figure from $15.1 million (153% YoY increase) to $12.2 million (536% YoY increase). While the absolute net income was lowered, the corrected growth rate reflects substantially stronger year-over-year performance. No other aspects of the original filing were revised.

• ·Form 8-K originally filed on March 11, 2026
• ·Item 9.01 includes Exhibit 99.1 (Press Release dated March 11, 2026)

16-03-2026

Aemetis, Inc. (AMTX) reported mixed FY 2025 results compared to FY 2024, with California Ethanol volumes declining 6.6% to 57 million gallons and 9.0% for WDG to 374 thousand tons, while average prices rose slightly for ethanol (+3.6% to $2.03/gallon) but fell for WDG (-9.2% to $80.1/ton). India Biodiesel saw sharp drops in volumes (-71.6% to 21 thousand metric tons, capacity utilization -72% to 14%) and refined glycerin (-84.6% to 1.0 thousand tons), though glycerin prices surged 69.5% to $1,093/ton. Positively, California Dairy RNG gas sales grew 32.1% to 399 thousand MMBtu (+11.0% price) and LCFS credits rose 59.6% to 83 thousand, offsetting declines despite RIN prices falling 17.8%.

• ·California Ethanol operated at 104% of nameplate capacity in FY 2025 vs 110% in FY 2024 (-5.9%).
• ·India Biodiesel operated at 14% of nameplate capacity in FY 2025 vs 50% in FY 2024 (-72%).

16-03-2026

Ernexa Therapeutics Inc. filed an S-3 shelf registration statement to potentially raise capital, highlighting its preclinical pipeline including ERNA-101 for platinum-resistant ovarian cancer (with IND submission planned for 2026 and Phase I trial in H2 2026) and ERNA-201 for autoimmune disorders. On February 10, 2026, the company completed a public offering raising net proceeds of approximately $9.5M through 19M shares and warrants at $0.50 combined, plus pre-funded warrants for 2M shares at $0.49, boosting stockholders’ equity from $2.4M at December 31, 2025 above the Nasdaq $2.5M threshold. However, the common stock bid price has traded below $1.00 since February 3, 2026, risking a Nasdaq deficiency notice and potential delisting given a recent 1-for-15 reverse stock split on June 10, 2025.

• ·Authorized common stock: 150,000,000 shares; preferred stock: 1,000,000 shares.
• ·Series A Preferred Stock: $0.10 per share annual cumulative dividend; $1.00 per share liquidation preference; conversion rate ~0.0137 common shares per preferred share (as of Dec 31, 2024 post-reverse split).
• ·Warrants (ERNAW): exercise price $0.68/share, expire on 5-year anniversary or 180 days after Phase 1 ERNA-101 first cohort data.
• ·Nasdaq minimum requirements: $1.00 bid price; $2.5M equity or $35M MVLS or $500K net income.

16-03-2026

Allison Transmission Holdings, Inc. (ALSN) filed an 8-K/A on March 16, 2026, amending its January 2, 2026 original 8-K to provide required financial statements and pro forma information under Item 9.01 for the January 1, 2026 acquisition of Dana Incorporated's off-highway business (Dana Business) for $2.732 billion, financed via cash on hand and debt. The deal stems from a June 11, 2025 Stock Purchase Agreement. No performance metrics or period-over-period comparisons are detailed in the filing itself, with exhibits referencing audited financials for years ended December 31, 2024 and 2023, and unaudited nine-month data as of September 30, 2025.

• ·Stock Purchase Agreement dated June 11, 2025
• ·Audited combined financial statements of Dana Business for years ended December 31, 2024 and December 31, 2023 (Exhibit 99.1)
• ·Unaudited condensed combined financial statements as of September 30, 2025 and for nine months ended September 30, 2025 and 2024 (Exhibit 99.2)
• ·Pro forma condensed combined balance sheet as of September 30, 2025 and statements of operations for nine months ended September 30, 2025 and year ended December 31, 2024 (Exhibit 99.3)

16-03-2026

The 21Shares Dogecoin ETF (TDOG) filed its annual 10-K for the period from inception on September 17, 2025, to September 30, 2025, reporting total assets, net assets, and paid-in capital of $100, with 2 shares issued and outstanding at a net asset value per share of $50.00. No net investment loss, unrealized gains/depreciation, or redemptions occurred during this short inaugural period. However, the filing highlights risks from pseudonymous Dogecoin ownership and potential large-scale sales by substantial holders, which could adversely impact Dogecoin price and ETF shares.

• ·Filing CIK: 0002064314
• ·Entity File Number: 001-43049
• ·Entity Tax ID: 33-7038007
• ·Incorporated in MD
• ·Address: 477 Madison Avenue, 6th Floor, New York, NY 10022
• ·Phone: (646) 370-6016

16-03-2026

Sprott Physical Silver Trust (PSLV) filed its Annual Report on Form 40-F dated March 16, 2026, providing an overview of the Trust's structure, investment and operating restrictions, silver sector context, unit descriptions, net asset value calculation methods, market information, redemption processes, governance, fees, distribution policy, tax considerations, and risk factors. The document includes details on valuation procedures for cash, receivables, liabilities, and portfolio transactions, but contains no specific financial performance metrics, period-over-period comparisons, or quantitative data on assets, income, or changes.

16-03-2026

MSC Income Fund, Inc. (NYSE: MSIF) announced the closing of a $150.0 million private investment grade notes offering on March 13, 2026. The unsecured notes bear a fixed interest rate of 6.34% per year, payable semiannually, and mature on May 31, 2029, with optional redemption at par plus accrued interest and a potential make-whole premium. Net proceeds will initially repay a portion of outstanding debt under its revolving credit facility, with re-borrowing to fund investments, operating expenses, and general corporate purposes.

• ·Notes are unsecured and may be redeemed in whole or in part at MSC Income’s option.
• ·Fund's private loan portfolio companies generally have annual revenues between $25M and $500M.
• ·Fund's lower middle market portfolio companies generally have annual revenues between $10M and $150M.
• ·Notes not registered under Securities Act of 1933 and subject to state securities laws exemptions.

16-03-2026

CO2 Energy Transition Corp., a SPAC, reported net income of $1.65M for FY 2025, up significantly from $2.6K in 2024, driven by $2.88M in interest income on Trust Account investments which grew to $72.1M from $69.3M. However, cash declined 70% to $288K, G&A expenses rose 163% to $646K leading to higher operating losses, and stockholders' deficit worsened 42% to $(1.79M). Total assets increased modestly to $72.5M, primarily from accretion on 6.9M redeemable shares now at $10.35/share.

• ·Net cash used in operating activities increased to $745K in 2025 from $306K in 2024.
• ·Income tax provision rose to $579K in 2025 from $61K in 2024.
• ·Deferred underwriting fee steady at $2.07M.

16-03-2026

NextPlat Corp has issued a proxy statement for a virtual Special Meeting of stockholders on March 27, 2026, seeking approval for Proposal 1 to amend its Articles of Incorporation, authorizing the Board to effect one or more reverse stock splits of common stock at ratios from 1-for-5 to 1-for-50 (aggregate not exceeding 1-for-50) anytime prior to March 27, 2028, with 26,976,215 shares outstanding as of the March 2, 2026 record date. Proposal 2 allows adjournment if needed to solicit more proxies for Proposal 1. No financial performance metrics or period comparisons are provided in the filing.

• ·Common stock par value: $0.0001 per share
• ·Record Date: March 2, 2026
• ·Special Meeting: March 27, 2026 at 10:00 AM EDT (virtual only)
• ·Reverse stock split authority expires: March 27, 2028

16-03-2026

Blend Labs reported total revenue of $123.6M for FY 2025, up 7% YoY from $115.8M, driven by 34% growth in Consumer Banking Suite to $45.2M, though Mortgage Suite declined 6% to $69.2M and Professional Services grew modestly 3%. Gross profit rose 10% to $91.2M with margin expansion to 74%, operating expenses fell 15% to $112.9M, and net loss narrowed sharply to $7.0M from $43.4M YoY. Operating cash flow turned positive at $14.4M versus negative $8.2M prior year.

• ·Software platform revenue $114.4M (93% of total) in FY 2025, up from $106.9M in 2024.
• ·R&D expenses down 29% YoY to $32.8M; Sales & marketing down 16% to $29.1M; G&A up 10% to $50.1M.
• ·No interest expense in FY 2025 vs $6.7M in 2024.
• ·Net cash decrease of $2.5M in FY 2025 after $11.3M increase in 2024.
• ·Stock-based compensation $29.0M in FY 2025, down from $27.9M in 2024 but up from $45.6M in 2023.

16-03-2026

Surf Air Mobility Inc. (SRFM) filed a Form S-3 shelf registration statement on March 13, 2026, for the resale of up to 6,131,995 shares of common stock by selling stockholders, with the company bearing registration costs but receiving no proceeds. The filing confirms SRFM's status as an emerging growth company and smaller reporting company, with common stock listed on NYSE (SRFM) closing at $1.88 per share on March 12, 2026. Corporate governance includes restrictions limiting Non-Citizens to 25.0% of voting interest and 49.0% of equity securities.

• ·Permitted Holders (Kuzari Investor 94647 LLC, Sudhin Shahani, Liam Fayed and affiliates) retain voting rights if Non-Citizen ownership exceeds 25.0%, reduced pro rata.
• ·Registrant classified as non-accelerated filer, smaller reporting company, and emerging growth company.
• ·Principal executive offices: 12111 Crenshaw Blvd., Hawthorne, CA 90250.

16-03-2026

Capital One Financial Corporation filed a Form 8-K on March 13, 2026 (filing date March 16, 2026), furnishing monthly charge-off and delinquency metrics as of and for the month ended February 28, 2026, under Regulation FD Disclosure (Item 7.01). The metrics are detailed in Exhibit 99.1, which is not deemed 'filed' for liability purposes. No specific numerical data on charge-offs or delinquencies is provided in the filing body.

• ·Commission File Number: 001-13300
• ·IRS Employer Identification No.: 54-1719854
• ·Principal executive offices: 1680 Capital One Drive, McLean, Virginia 22102
• ·Telephone: (703) 720-1000

16-03-2026

Mountain Crest Acquisition Corp. V reported a widened net loss of $431,161 for the year ended December 31, 2025, up 15% YoY from $374,454 in 2024, driven by sharply lower interest income on the Trust Account ($46,114 vs. $265,306). While general and administrative expenses declined 24% to $471,782 and net cash used in operating activities improved to $742K from $921K, total assets fell to $874K from $1.3M, cash dropped to $12K, and the Trust Account balance decreased 27% to $841K amid ongoing redemptions reducing redeemable shares to 72,123 from 101,104. Stockholders' deficit worsened to $(3.7M) from $(3.4M), with related-party promissory note rising to $1.3M.

• ·Proposal to amend Charter to extend Combination Period to November 16, 2024 with $0.10 per Public Share deposits for three-month extensions.
• ·Deferred underwriting commission obligation of $2.07M upon business combination.
• ·Conversion of $600K related-party promissory note to equity in 2024.
• ·Reversal of $194K excise tax payable in 2025.
• ·Net cash provided by investing activities $363K in 2025 (vs $4.72M in 2024), mainly from $336K redemption withdrawals.

16-03-2026

Sprott Physical Platinum & Palladium Trust (SPPP) filed its 40-F annual report on March 16, 2026, including certification by the principal executive officer affirming that the financial statements fairly present the Trust's financial condition, results of operations, and cash flows for the periods presented. The report provides an overview of the Trust's structure, investment and operating restrictions, platinum and palladium sectors, unit description, NAV calculation methodology, market details, governance, fees, distribution policy, tax considerations, and risk factors. No specific financial metrics, period-over-period comparisons, or performance data are detailed in the provided excerpts.

16-03-2026

Vanguard Green Investment Ltd reported zero revenue for both the three and six months ended January 31, 2026, with net losses widening significantly to $30,132 (3M, +125% YoY) and $47,129 (6M, +62% YoY) due to elevated general and administrative expenses. Total assets contracted 66.5% to $5,110 from $15,258 as of July 31, 2025, while cash equivalents dropped to $55 from $93; stockholders' deficit deepened to $(771,707) from $(724,578). Non-current liabilities improved with a 48% reduction to $18,093, but current liabilities rose 7.6% to $758,724, largely from increased director loans.

• ·Prepayments decreased to $5,055 from $15,165 as of Jul 31, 2025.
• ·Loan from director increased to $484,543 from $445,001.
• ·Amount due to related parties remained flat at $96,513.
• ·G&A expenses for six months rose to $43,495 from $23,698 YoY.

16-03-2026

Addentax Group Corp. (ATXG) entered into a stock purchase agreement on February 17, 2026, to acquire 34,200,000 shares (62.18% voting control on a fully-diluted basis) of Keemo Fashion Group Limited from Guang Wen Global Group Limited for approximately $5.5M, satisfied via partial transfer of an existing $17.5M bond. The deal is expected to close by May 1, 2026, making ATXG the controlling shareholder of Keemo Fashion, which operates apparel trading in China and a digital publishing platform in Malaysia. This 8-K/A filing amends the original February 19, 2026, 8-K solely to correct a typographical error in the seller's name.

• ·Bond issued August 24, 2023, with one-year tenor (renewable), governed by New York law
• ·Stock Purchase Agreement dated February 17, 2026 (Exhibit 10.1); Bond Transfer Agreement dated February 18, 2026 (Exhibit 10.2)

16-03-2026

Forgent Intermediate LLC reported strong revenue growth of 69% YoY to $296,404 for the three months ended December 31, 2025, with gross profit up 60% to $101,756, but operating income grew only 6% to $20,090 amid higher SG&A expenses, resulting in a net loss of $91 versus prior year profit of $6,431 due to elevated interest expense. For the six months ended December 31, 2025, revenues surged 76% YoY to $579,678, yet net income attributable to the LLC dipped 6% to $10,259, cash from operations plummeted 90% to $6,007, and cash balance declined to $106,165 from $111,322 at June 30 and $215,837 prior year.

• ·Long-term debt increased to $579,006 (net) at Dec 31, 2025 from $496,934 at Jun 30, 2025, with $594,000 proceeds offset by $511,110 payments.
• ·Capex rose to $56,368 for 6M ended Dec 31, 2025 from $24,376 prior year.
• ·Accounts receivable increased to $251,017 at Dec 31, 2025 from $159,970 at Jun 30, 2025.